Results of the studies could provide the basis for developing a blood test that would enable early detection of breast cancer.
According to A&G, the award was one of 12 grants totaling more than $7 million awarded in 2007 by the Avon Foundation as part of its Breast Cancer Prevention Research Initiative, and it is the first ever awarded by the foundation to a private company.
Ginette Serrero, CEO of A&G, said: “We greatly appreciate Avon’s support as we accelerate the development of a GP88 blood diagnostic test and our goal of establishing GP88 as the most sensitive and reliable marker for early breast cancer detection.”